Found: 13
Select item for more details and to access through your institution.
Vesatolimod, a Toll-like Receptor 7 Agonist, Induces Immune Activation in Virally Suppressed Adults Living With Human Immunodeficiency Virus–1.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 11, p. e815, doi. 10.1093/cid/ciaa1534
- By:
- Publication type:
- Article
The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 599, p. 1, doi. 10.1126/scitranslmed.abg3071
- By:
- Publication type:
- Article
Phase 1B Study of Momelotinib Combined With Trametinib in Metastatic, Kirsten Rat Sarcoma Viral Oncogene Homolog-Mutated Non-Small-Cell Lung Cancer After Platinum-Based Chemotherapy Treatment Failure.
- Published in:
- 2018
- By:
- Publication type:
- journal article
MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism.
- Published in:
- PLoS ONE, 2009, v. 4, n. 12, p. 1, doi. 10.1371/journal.pone.0008445
- By:
- Publication type:
- Article
Brief Report: Loss of p15Ink4b Accelerates Development of Myeloid Neoplasms in Nup98-HoxD13 Transgenic Mice.
- Published in:
- Stem Cells, 2014, v. 32, n. 5, p. 1361, doi. 10.1002/stem.1635
- By:
- Publication type:
- Article
Concise Review: Erythroid Versus Myeloid Lineage Commitment: Regulating the Master Regulators.
- Published in:
- Stem Cells, 2013, v. 31, n. 7, p. 1237, doi. 10.1002/stem.1379
- By:
- Publication type:
- Article
Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 11, p. 2276, doi. 10.1111/cts.13627
- By:
- Publication type:
- Article
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemia.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 12, p. 1395, doi. 10.1093/jjco/hyaa153
- By:
- Publication type:
- Article
Impact of COVID‐19 on the Conduct and Design of Clinical Trials: IQ Consortium Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 1, p. 26, doi. 10.1002/cpt.3242
- By:
- Publication type:
- Article
Semi‐Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 416, doi. 10.1002/cpt.2439
- By:
- Publication type:
- Article
PHARMACOKINETICS INFORMS REMDESIVIR DOSING FOR PATIENTS WITH SEVERE RENAL IMPAIRMENT.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 201
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 5, p. 896, doi. 10.1111/cts.12840
- By:
- Publication type:
- Article